Paroxetine in the treatment of generalized anxiety disorder: Results of a placebo-controlled, flexible-dosage trial

Journal of Clinical Psychiatry

Volumn 62, Issue 5, 2001, Pages 350-357

  Pollack, M H ^a   Zaninelli, R ^a   Goddard, A ^a   McCafferty, J P ^a   Bellew, K M ^a   Burnham, D B ^a   Iyengar, M K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PAROXETINE; PLACEBO;

ADULT; AGED; ANXIETY NEUROSIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD; OUTPATIENT CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM;

EID: 0034965985     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v62n0508     Document Type: Article

References (44)

1. The empirical basis of generalized anxiety disorder
2. Comparison of RDC, DSM-III, DSM-III-R diagnostic criteria for generalized anxiety disorder
3. Generalized anxiety disorder and panic disorder in the elderly: A review
4. Impairment in pure and comorbid generalized anxiety disorder and major depression at 12 months in two national surveys
5. Quality of life and psychiatric comorbidity in panic disorder and generalized anxiety disorder
6. Generalized anxiety disorder: Longitudinal course and pharmacologic treatment
7. Mental disorders and disability among patients in a primary group practice
8. Importance of establishing the diagnosis of persistent anxiety
9. Epidemiology and comorbidity of anxiety, disorders in the elderly
10. Epidemiology and psychopharmacology of anxiety in medical patients
11. Generalized anxiety disorder in primary care: The precursor/modifier pathway to increased health care utilization
12. Use of benzodiazepines in anxiety disorders
13. Anxiety disorders
14. Nonbenzodiazepine anxiolytics
15. Antidepressants for the treatment of generalized anxiety disorder: A placebo-controlled comparison of imipramine, trazodone and diazepam
16. Differential effects of alprazolam and imipramine in generalized anxiety disorder: Somatic versus psychic symptoms
17. An open trial of nefazodone in adult patients with generalized anxiety disorder
18. Efficacy, safety and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder
19. Efficacy of extended release venlafaxine in nondepressed outpatients with generalized anxiety disorder
20. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial
21. A study comparing paroxetine, placebo and imipramine in depressed patients
22. A comparison of paroxetine and placebo in depressed outpatients
23. Double-blind, fixed dose, placebo-controlled study of paroxetine in the treatment of panic disorder
24. Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder
25. Paroxetine treatment of generalized social phobia (social anxiety disorder)
26. Paroxetine efficacy in the treatment of generalized anxiety disorder
27. The Mini-International Neuropsychiatric Interview (MINI): The development and validation of a structured diagnostic psychiatric interview fbr DSM-IV and ICD-10
28. Paroxetine in the elderly: A comparative meta-analysis against standard antidepressant pharmacotherapy
29. The assessment of anxiety states by rating
30. A new depression scale designed to be sensitive to change
31. The hospital anxiety and depression scale
32. The measurement of disability
33. Assessing impairment in patients with panic disorder: The Sheehan Disability Scale
34. Clinical guidelines for establishing remission in patients with depression and anxiety
35. Fluoxetine in posttraumatic stress disorder: A randomised, double-blind study
36. Buspirone in the treatment of panic disorder: A controlled pilot comparison with clorazepate
37. Buspirone and diazepam in anxiety: A controlled study
38. Paroxetine: An update of is pharmacology and therapeutic use in depression and a review of its use in other disorders
39. A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder
40. Abecarnil for the treatment of generalized anxiety disorder: A placebo-controlled comparison of two dosage ranges of abecarnil and buspirone
41. Paroxetine treatment of GAD: A double-blind, placebo-controlled trial
42. Generalized anxiety disorder (ICD-10) in primary care from a cross-cultural perspective: A valid diagnostic entity